의료기기 이야기

The start of 2024 has seen a flurry of activity from the UK’s Medicines and Healthcare Regulatory Agency (MHRA) regarding medical device legislation.These updates have greatly increased the UK’s capacity to certify medical devices. Since the publication of the UK regulatory roadmap (January 9), there have been several significant updates to the list of UK-approved bodies for medical devices, inc..

식품의약품안전처에서 2024년 체외진단의료기기 허가 심사 민원설명회를 개최하였으며, 발표자료를 배포하였다. 민원인 안내서 > 민원설명회 자료 > 2024년 제1차 체외진단의료기기 허가심사 민원설명회 | 식품의약품안전평가원 (nifds.go.kr) 민원인 안내서 > 민원설명회 자료 > 2024년 제1차 체외진단의료기기 허가심사 민원설명회 | 식품의 2024년 제1차 체외진단의료기기 허가심사 민원설명회 자료를 첨부합니다. 업무에 참고하시기 바랍니다. www.nifds.go.kr

In 2017, the EU introduced new rules for medical devices and in vitro diagnostics to ensure a better protection of public health and patient safety. Despite considerable progress in transitioning to these rules and the additional time given to the sector to implement them, the transition remains slow. In 2023, the Commission took measures to ensure the availability of medical devices. Today, we ..

The European Commission’s Medical Device Coordinating Group (MDCG) has updated its priorities regarding the In Vitro Diagnostic Medical Devices Regulation (IVDR). The MDCG updated its Joint implementation and preparedness plan for the IVDR to reflect ongoing progress of its work and to set new priorities for the European Regulation (EU) 2017/746 (IVDR). IVDR plan organization The 20-page documen..

To help medical device and IVD manufacturers understand the national language requirements under the Medical Devices Regulation (2017/745, MDR) and In Vitro Diagnostic Devices Regulation (2017/746, IVDR), the European Commission recently published two tables on its website (January 17) with links for the relevant legal provisions for each member state. The MDR and IVDR contain regulatory require..

The European Commission’s Directorate-General for Health and Food Safety (DG SANTE) - through the European Health and Digital Executive Agency (HaDEA) - has commissioned a “Study supporting the monitoring of availability of medical devices on the EU market”. The study started in December 2022 and will be running for 36 months (December 2025). The study has been contracted to a consortium led by ..

On 5 December 2023, the European Commission adopted an implementing act designating 5 EU reference laboratories (EURLs) in the field of in vitro diagnostic medical devices (IVDs). These EURLs will be involved in conformity assessment of high-risk (class D) IVDs as well as carry out certain advisory tasks. The designated EURLs together cover the following categories of class D IVDs: Hepatitis and..

MDCG에서 발행된 문서를 기반으로 제조업체와 유럽대리인을 대상으로 설문조사를 진행하고 있다. 관심이 있으신 업체의 경우에는 확인 바랍니다. ▶ 기간: 2024년 01월 15일까지 (CET 23:59:59 까지) EUSurvey - Survey (europa.eu) Study supporting the monitoring of availability of medical devices on the EU market Surveys for MD and IVD manufacturers and aut ec.europa.eu

▶ KTR에서 체외진단의료기기와 감염병 관련하여 설명회를 개최한다. ▶ 일시: 2023년 10월 31일(화) 오후 1시 ~ 오후 5시 ▶ 장소: 나인트리 프리미어 로카우스 호텔 서울 용산 (5층 하모니홀) ▶ 대상: 체외진단의료기기 제조업체 및 산/학/연 전문가 등 ▶ 주제: 체외진단의료기기 기술세미나 (기술문서, 임상적 성능시험 계획서, 바이오헬스 분야 표준화 로드맵) 국가 감염병 진단검사체계, 감염병 진단시약 비상생산기관 운영(안) 설명회 ▶ 사전신청기간: 2023년 10월 27일(금)까지 ▶ 사전신청링크: 감염병 진단시약 비상생산기관 지정 요건 설명회 참석 여부 (google.com)

FDA updated of the list of cleared or approved companion diagnostic devices (in vitro and imaging tools). - Device: CRCDx RAS mutation detection assay kit - Generic name: somatic gene mutation detection system - Applicant: EntroGen, Inc - PMA number: P220005 - Approval order statement Approval for the CRCdx® RAS Mutation Detection Kit. The device is a qualitative real-time PCR in vitro diagnosti..